Opportunities and challenges for T cell-based influenza vaccines

Area of Science:

• Immunology
• Vaccinology
• Infectious Disease

Background:

• Influenza causes significant mortality and pandemic risk, with current vaccines having variable effectiveness.
• Influenza viruses rapidly change surface antigens, evading immune responses and necessitating improved vaccine strategies.
• While antibody induction is traditional, T cell responses are increasingly recognized for their protective role against influenza.

Purpose of the Study:

• To explore the potential of future influenza vaccines designed to elicit both T cell and antibody responses.
• To discuss the challenges and considerations for developing and evaluating next-generation influenza vaccines.
• To highlight the need for strategic and economic innovations in vaccine development and clinical trials.

Main Methods:

• Review of current evidence on T cell and antibody responses in influenza protection.
• Discussion of challenges in assessing T cell immunogenicity and vaccine effectiveness.
• Exploration of economic and strategic considerations for novel vaccine development.

Main Results:

• T cell responses, alongside antibodies, are crucial for protection against influenza.
• Assessing T cell responses requires more invasive methods and focus on severe disease prevention.
• Current vaccine development strategies may need re-evaluation to incorporate T cell induction.

Conclusions:

• Future influenza vaccines should aim to induce broad T cell effector functions and antibodies for enhanced protection.
• Overcoming challenges in T cell assessment and clinical trial design is critical for economic viability.
• Renewed efforts are justified to develop more effective influenza vaccines offering better defense against infection and severe outcomes.